Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6412 posts found.

Abbott announces two FDA clearances for life support system

April 26, 2023 Medical Communications

US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …
News

EMA validates marketing authorisation application for Jemperli with chemotherapy

April 25, 2023 Medical Communications

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …
News

NICE publishes Final Appraisal Document for multiple myeloma drug

April 25, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …
News

AstraZeneca and Ionis share positive results from phase 3 trial for eplontersen

April 25, 2023 Medical Communications

AstraZeneca and Ionis have announced positive results from their phase 3 NEURO-TTRansform trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …
News

NICE recommends treatment combination for advanced leukaemia

April 24, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …
News

Sanofi offers hepatitis A vaccine for UK children

April 24, 2023 Medical Communications

Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …
News

Aptar and Healint announce collaboration on CNS and immune system conditions management

April 24, 2023 Medical Communications

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …
News

RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy

April 21, 2023 Medical Communications

Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …
News

FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay

April 21, 2023 Medical Communications

Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …
News

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

April 20, 2023 Medical Communications

Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …
News

Eli Lilly partners with Ivy Tech Community College for scholarship programme

April 20, 2023 Medical Communications

Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …
News

ANGLE and BioView partner to develop a CTC-based HER2 assay

April 19, 2023 Medical Communications

ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …
News

FDA issues update around changes to COVID-19 vaccines’ EUAs

April 19, 2023 Medical Communications

The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …
News

Neuspera Medical receives FDA approval for peripheral nerve pain system

April 19, 2023 Medical Communications

Medical device company Neuspera Medical has announced that it has received FDA approval for its implantable system, used to treat …
News

GSK enters into £1.6bn deal to acquire Bellus Health

April 18, 2023 Medical Communications

UK-based GSK has announced its plans to acquire Bellus Health, a Canadian late-stage biopharmaceutical company which focuses on treatments for …
News
The Gateway to Local Adoption Series

Latest content

InnoScot highlights NHS Scotland’s progress towards net zero healthcare

August 11, 2026

NHS England approves delayed-release treatment for rare kidney disease

August 10, 2026

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

August 9, 2026

Functional lung imaging offers new possibilities for respiratory care

August 9, 2026

Five Facts about cardiovascular disease

August 9, 2026